IM Cannabis to Acquire MYM Nutraceuticals and Its Licensed Producer Subsidiary, Highland Grow
- Written by Newsfile
- Highland Grow is currently profitable on an EBITDA basis and the Transaction is expected to be immediately accretive to IMC
- Highland Grow is expected to generate net revenue of $29 million and $38 million and gross margins of 34% to 36% in 2021 and 2022, respectively[1]
- Purchase price implies 2.3x net revenue and 6.7x EBITDA in 2022 with synergies
- MYM...
